These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 20848144)

  • 21. Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea.
    Schwille-Kiuntke J; Mazurak N; Enck P
    Aliment Pharmacol Ther; 2015 Jun; 41(11):1029-37. PubMed ID: 25871571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. To "lump" or to "split" the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome?
    Moss-Morris R; Spence M
    Psychosom Med; 2006; 68(3):463-9. PubMed ID: 16738080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota.
    Jin Y; Ren X; Li G; Li Y; Zhang L; Wang H; Qian W; Hou X
    J Gastroenterol Hepatol; 2018 Feb; 33(2):443-452. PubMed ID: 28573746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal infection and irritable bowel syndrome.
    Parry S; Forgacs I
    Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):5-9. PubMed ID: 15647632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome.
    Gwee KA; Collins SM; Read NW; Rajnakova A; Deng Y; Graham JC; McKendrick MW; Moochhala SM
    Gut; 2003 Apr; 52(4):523-6. PubMed ID: 12631663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Post-infectious irritable bowel syndrome].
    Pallotti F; Fogacci E; Frisoni C; Serra M; Bellacosa L; Carini G; Cremon C; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
    Clin Ter; 2011; 162(2):157-61. PubMed ID: 21533323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Gastrointestinal Consequences are Frequent Following Sporadic Acute Infectious Diarrhea in a Tropical Country: A Prospective Cohort Study.
    Rahman MM; Ghoshal UC; Sultana S; Kibria MG; Sultana N; Khan ZA; Ahmed F; Hasan M; Ahmed T; Sarker SA
    Am J Gastroenterol; 2018 Sep; 113(9):1363-1375. PubMed ID: 30171215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging role of the gut microbiome in post-infectious irritable bowel syndrome: A literature review.
    Lupu VV; Ghiciuc CM; Stefanescu G; Mihai CM; Popp A; Sasaran MO; Bozomitu L; Starcea IM; Adam Raileanu A; Lupu A
    World J Gastroenterol; 2023 Jun; 29(21):3241-3256. PubMed ID: 37377581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-infectious irritable bowel syndrome.
    Rhodes DY; Wallace M
    Curr Gastroenterol Rep; 2006 Aug; 8(4):327-32. PubMed ID: 16836945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome.
    Pike BL; Paden KA; Alcala AN; Jaep KM; Gormley RP; Maue AC; Christmann BS; Elson CO; Riddle MS; Porter CK
    J Travel Med; 2015; 22(4):242-50. PubMed ID: 26058758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new rat model links two contemporary theories in irritable bowel syndrome.
    Pimentel M; Chatterjee S; Chang C; Low K; Song Y; Liu C; Morales W; Ali L; Lezcano S; Conklin J; Finegold S
    Dig Dis Sci; 2008 Apr; 53(4):982-9. PubMed ID: 17934822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review.
    Schmulson M; Bielsa MV; Carmona-Sánchez R; Hernández A; López-Colombo A; López Vidal Y; Peláez-Luna M; Remes-Troche JM; Tamayo JL; Valdovinos MA
    Rev Gastroenterol Mex; 2014; 79(2):96-134. PubMed ID: 24857420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric scores and persistence of irritable bowel after Campylobacter concisus infection.
    Nielsen HL; Engberg J; Ejlertsen T; Nielsen H
    Scand J Gastroenterol; 2014 May; 49(5):545-51. PubMed ID: 24646319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electroacupuncture Relieves Irritable Bowel Syndrome by Regulating IL-18 and Gut Microbial Dysbiosis in a Trinitrobenzene Sulfonic Acid-Induced Post-Inflammatory Animal Model.
    Song YF; Pei LX; Chen L; Geng H; Yuan MQ; Xu WL; Wu J; Zhou JY; Sun JH
    Am J Chin Med; 2020; 48(1):77-90. PubMed ID: 31918565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery.
    Marshall JK; Thabane M; Garg AX; Clark WF; Salvadori M; Collins SM;
    Gastroenterology; 2006 Aug; 131(2):445-50; quiz 660. PubMed ID: 16890598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
    Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carriage of CdtB Encoding Campylobacter spp., Salmonella enterica, and Yersinia entercolitica in Patients with Gastroenteritis and Irritable Bowel Syndrome.
    Ganji L; Shirazi MH; Ebrahimi-Daryani N; Eslami P; Rahbar M; Zali MR; Alebouyeh M
    Dig Dis Sci; 2022 Dec; 67(12):5522-5528. PubMed ID: 35357609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is irritable bowel syndrome an inflammatory disorder?
    De Giorgio R; Barbara G
    Curr Gastroenterol Rep; 2008 Aug; 10(4):385-90. PubMed ID: 18627650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis.
    Villani AC; Lemire M; Thabane M; Belisle A; Geneau G; Garg AX; Clark WF; Moayyedi P; Collins SM; Franchimont D; Marshall JK
    Gastroenterology; 2010 Apr; 138(4):1502-13. PubMed ID: 20044998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and Risk Factors of Post-Infection Irritable Bowel Syndrome After Campylobacter Enteritis.
    Berumen A; Lennon R; Breen-Lyles M; Griffith J; Patel R; Boxrud D; Decuir M; Farrugia G; Smith K; Grover M
    Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1855-1863.e1. PubMed ID: 32711045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.